Eye diseases burden in China in the past 30 years

doi:10.3724/zdxbyxb-2021-0246

J Zhejiang Univ (Med Sci)

2021, Vol. 50

Issue (4): 420-428 DOI: 10.3724/zdxbyxb-2021-0246

Eye diseases burden in China in the past 30 years

CHEN Binbin(

),LOU Lixia(

),YE Juan

Ophthalmology Center, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China

Download:

HTML( 14 )

PDF(2907KB)
Export: BibTeX | EndNote (RIS)

Abstract

Objective: To investigate the national burden of eye diseases in China from 1990 to 2019. Methods: The national burden of eye diseases in China, including case numbers, prevalence rate, age-standardized prevalence rate (ASR), disability-adjusted life year (DALY), DALY rate and age-standardized DALY rate (ASD) were calculated and stratified by sex and age. The trends of eye diseases burden from 1990 to 2019 and the correlation between eye diseases burden and human development index (HDI) were analyzed. Results: In 2019, the total case number of eye diseases in China was 0.21 billion, the ASR was 9511/10⁵, the total number of DALY was 4.72 million, and the ASD was 247.4/10⁵. Near vision loss caused the greatest burden, followed by refraction disorders and cataract, with ASD being 73.8/10⁵, 70.3/10⁵ and 59.2/10⁵, respectively. Men had lower risks of eye diseases than women. People aged 50– <70?years old and ≥70?years old had the greatest burden of eye diseases. Compared with the year 1990, the total case number increased by 134.6% and DALY by 113.0% in 2019. The ASD of all decreased by 7.5%, and was negatively correlated with national HDI. Conclusions: Near vision loss, refraction disorders and cataract are of heavy disease burden in China. Although the ASD of eye diseases is decreased with the development of the national socioeconomic status, the eye diseases burden in China still increased with population growth and aging.

Key words： Eye disease Prevalence Disability-adjusted life year Burden of disease Human development index

Received: 29 January 2021 Published: 01 November 2021

CLC:	R77
	R195.4

Corresponding Authors: LOU Lixia E-mail: 2201015@zju.edu.cn;loulixia110@zju.edu.cn

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Binbin
	LOU Lixia
	YE Juan

Cite this article:

CHEN Binbin,LOU Lixia,YE Juan. Eye diseases burden in China in the past 30 years. J Zhejiang Univ (Med Sci), 2021, 50(4): 420-428.

URL:

http://www.zjujournals.com/med/10.3724/zdxbyxb-2021-0246 OR http://www.zjujournals.com/med/Y2021/V50/I4/420

中国眼病疾病负担现状及三十年变化趋势

目的：分析1990—2019年中国眼病的疾病负担状况和变化趋势。方法：利用2019年全球疾病负担研究结果，分析1990—2019年中国眼病患病人数、患病率、年龄标化患病率、伤残调整生命年（DALY）、DALY率、年龄标化DALY率及变化趋势，以及年龄标化DALY率与国家社会经济发展水平之间的相关性。结果：2019年中国人群眼病患病人数为2.1亿，年龄标化患病率为9511/10万；总DALY为472万，年龄标化DALY率为247.4/10万。疾病负担较重的眼病依次为近视力丧失、屈光性眼病和白内障，年龄标化DALY率分别为73.8/10万、70.3/10万和59.2/10万。男性患各类眼病的风险均低于女性。疾病负担较重的年龄段为50~<70岁和≥70岁。相比于1990年，2019年中国人群眼病患病数增加了134.6%，总DALY增加了113.0%。然而，总体年龄标化DALY率下降了7.5%，与国家社会经济发展水平呈明显负相关（P<0.01）。结论：在中国，近视力丧失、屈光性眼病和白内障是疾病负担较重的眼病。尽管近年来随着国家的发展，眼病年龄标化DALY率有所下降，但人口增长和老龄化导致了眼病造成的疾病负担显著上升。

关键词： 眼病, 患病率, 伤残调整生命年, 疾病负担, 人类发展指数

Table 1 Prevalence, prevalence rates, and age-standardized prevalence rates of eye diseases in China in the year 1990 and 2019

Figure 1 Prevalence, prevalence rates and age-standardized prevalence rates of eye diseases in China during 1990 and 2019

Table 2 DALYs, DALY rates, and age-standardized DALY rates of eye diseases in China in the year 1990 and 2019

Table 3 DALYs and DALY rates of eye diseases in population of different ages in China in the year 1990 and 2019

Figure 2 DALYs, DALY rates and age-standardized DALY rates of eye diseases in China during 1990 and 2019

Figure 3 Line regression between age-standardized DALY rates and human development index in China during 1990 and 2019

Table 4 Linear regression results of age-standardized DALY rates of eye diseases and human development index in China during 1990 and 2019


[1]	Global Health Data Exchange. Global burden of disease study 2019 data resources[EB/OL]. [2020-12-28]. http://ghdx.healthdata.org/gbd-2019

[2]	高　华, 陈秀念, 史伟云. 我国盲的患病率及主要致盲性疾病状况分析[J]. 中华眼科杂志, 2019, 55(8): 625-628 GAO Hua, CHEN Xiunian, SHI Weiyun. Analysis of the prevalence of blindness and major blinding diseases in China[J]. Chinese Journal of Ophthalmology, 2019, 55(8): 625-628. (in Chinese)

[3]	World Health Organization. What is VISION 2020? [EB/OL]. [2020-10-15]. https://www.who.int/blindness/partnerships/vision2020/en/

[4]	中华人民共和国国家卫生健康委员会. 国家卫生计生委关于印发“十三五”全国眼健康规划(2016—2020年)的通知[EB/OL]. (2016-11-09)[2020-10-01]. http://www.nhc.gov.cn/wjw/ghjh/201611/9463afb00ac84910bb3c22f8629cf90a.shtml National Health Commission of the People’s Republic of China. Notice of “The 13th Five-Year plan” of national eye health (2016-2020) published by National Health and Family Planning Commission[EB/OL]. (2016-11-09)[2020-10-01]. http://www.nhc.gov.cn/wjw/ghjh/201611/9463afb00ac84910bb3c22f8629cf90a.shtml. (in Chinese)

[5]	Global Health Data Exchange. GBD results tool[EB/OL]. [2020-12-24]. http://ghdx.healthdata.org/gbd-results-tool

[6]	United Nations Development Programme. Human development report 2020[EB/OL]. [2021-01-12]. http://hdr.undp.org/en/2020-report

[7]	ZHAOJ, XUX, ELLWEINL B, et al.Prevalence of vision impairment in older adults in rural China in 2014 and comparisons with the 2006 China nine-province survey[J]Am J Ophthalmol, 2018, 81-93. doi: 10.1016/j.ajo.2017.10.016

[8]	HOLDENB A, FRICKET R, HOS M, et al.Global vision impairment due to uncorrected presbyopia[J]Arch Ophthalmol, 2008, 126( 12): 1731. doi: 10.1001/archopht.126.12.1731

[9]	中华人民共和国国家统计局. 中华人民共和国2019年国民经济和社会发展统计公报[EB/OL]. (2020-02-28)[2020-10-05]. http://www.stats.gov.cn/tjsj/zxfb/202002/t20200228_1728913.html National Bureau of Statistics of the People’s Republic of China. National economic and social development report of the People’s Republic of China in 2019[EB/OL]. (2020-02-28)[2020-10-05]. http://www.stats.gov.cn/tjsj/zxfb/202002/t20200228_1728913.html. (in Chinese)

[10]	ZHAOJ, XUX, ELLWEINL B, et al.Causes of visual impairment and blindness in the 2006 and 2014 nine-province surveys in rural China[J]Am J Ophthalmol, 2019, 80-87. doi: 10.1016/j.ajo.2018.09.011

[11]	徐　捷, 徐　亮. 近视防控的六维度评估及防控模式[J]. 中华眼视光学与视觉科学杂志, 2018, 20(3): 129-132 XU Jie, XU Liang. Six dimensional evaluation for myopia prevention and control[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2018, 20(3): 129-132. (in Chinese)

[12]	董彦会, 刘慧彬, 王政和, 等. 2005—2014年中国7~18岁儿童青少年近视流行状况与变化趋势[J]. 中华预防医学杂志, 2017, 51(4): 285-289 DONG Yanhui, LIU Huibin, WANG Zhenghe, et al. The epidemic status and secular trends of myopia prevalence for Chinese children and adolescents aged 7–18 years from 2005 to 2014[J]. Chinese Journal of Preventive Medicine, 2017, 51(4): 285-289. (in Chinese)

[13]	中华人民共和国教育部. 教育部等八部门关于印发《综合防控儿童青少年近视实施方案》的通知[EB/OL]. (2018-08-30)[2020-10-20]. http://www.moe.gov.cn/srcsite/A17/moe_943/s3285/201808/t20180830_346672.html The Ministry of Education of the People’s Republic of China. Notice of Implementation plan of comprehensive prevention and control of myopia in children and adolescents published by eight ministries including the Ministry of Education[EB/OL]. (2018-08-30)[2020-10-20]. http://www.moe.gov.cn/srcsite/A17/moe_943/s3285/201808/t20180830_346672.html. (in Chinese)

[14]	中国防盲治盲网. 2017年中国白内障复明手术报送情况排名[EB/OL]. (2018-03-28)[2020-10-18]. http://www.moheyes.com/News/Details/3bed44657e8c-40e38532-25eeb128565b National Blindness Prevention and Treatment. The ranks of numbers of cataract surgery in China in 2017[EB/OL]. (2018-03-28)[2020-10-18]. http://www.moheyes.com/News/Details/3bed4465-7e8c-40e3-8532-25eeb128565b. (in Chinese)

[15]	MURTHYG V S, JOHNN, SHAMANNAB R, et al.Elimination of avoidable blindness due to cataract: where do we prioritize and how should we monitor this decade?[J]Ind J Ophthalmol, 2012, 60( 5): 438-455. doi: 10.4103/0301-4738.100545

[16]	刘　平, 邹海东, 胡爱莲, 等. 白内障防盲治盲工作的关键要素[J]. 中华眼科杂志, 2017, 53(11): 801-804 LIU Ping, ZOU Haidong, HU Ailian, et al. Critical elements of cataract prevention work in China[J]. Chinese Journal of Ophthalmology, 2017, 53(11): 801-804. (in Chinese)

[17]	FLAXMANS R, BOURNER R A, RESNIKOFFS, et al.Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis[J/OL]Lancet Glob Health, 2017, 5( 12): e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5

[18]	谢立信. 对我国防盲治盲工作的几点建议[J]. 中华眼科杂志, 2017, 53(1): 1-2 XIE Lixin. Some suggestions for blindness prevention and treatment in China[J]. Chinese Journal of Ophthalmology, 2017, 53(1): 1-2. (in Chinese)

[19]	中华人民共和国人力资源社会保障部. 人力资源社会保障部关于印发国家基本医疗保险、工伤保险和生育保险药品目录(2017年版)的通知[EB/OL]. (2017-02-21)[2020-10-20]. http://www.mohrss.gov.cn/SYrlzyhshbzb/shehuibaozhang/zcwj/yiliao/201702/t20170223_266775.html The Ministry of Human Resources and Social Security of the People’s Republic of China. Notice of Drug directory from national basic medical insurance, employment injury insurance and maternity insurance (2017) published by the Ministry of Human Resources and Social Security[EB/OL]. (2017-02-21) [2020-10-20]. http://www.mohrss.gov.cn/SYrlzyhshbzb/shehuibaozhang/zcwj/yiliao/201702/t20170223_266775.html. (in Chinese)

[20]	WANGY X, XUL, YANGH, et al.Prevalence of glaucoma in North China: the Beijing eye study[J]Am J Ophthalmol, 2010, 150( 6): 917-924. doi: 10.1016/j.ajo.2010.06.037

[21]	HEM, FOSTERP J, GEJ, et al.Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan district, Guangzhou[J]Invest Ophthalmol Vis Sci, 2006, 47( 7): 2782-2788. doi: 10.1167/iovs.06-0051

[22]	LIANGY, JIANGJ, OUW, et al.Effect of community screening on the demographic makeup and clinical severity of glaucoma patients receiving care in urban China[J]Am J Ophthalmol, 2018, 1-7. doi: 10.1016/j.ajo.2018.07.013

[23]	梁远波, 江俊宏, 王宁利. 中国青光眼流行病学调查研究回顾[J]. 中华眼科杂志, 2019, 55(8): 634-640 LIANG Yuanbo, JIANG Junhong, WANG Ningli. Review of epidemiological studies of glaucoma in China[J]. Chinese Journal of Ophthalmology, 2019, 55(8): 634-640. (in Chinese)

[24]	中华医学会眼科学分会青光眼学组, 中国医学装备协会眼科人工智能学组. 中国基于眼底照相的人工智能青光眼辅助筛查系统规范化设计及应用指南[J]. 中华眼科杂志, 2020, 56(6): 423-432 The Subspecialty Group of Glaucoma, Chinese Ophthalmological Society, The Subspecialty Group of Ophthalmological Artificial Intelligence, China Association of Medical Equipment. Standardized design and application guideline for artificial intelligence-aided screening system for glaucoma based on fundus image in China[J]. Chinese Journal of Ophthalmology, 2020, 56(6): 423-432. (in Chinese)

[1]	HU Zhenzhen,YANG Jianbin,HU Lingwei,ZHAO Yunfei,ZHANG Chao,YANG Rulai,HUANG Xinwen. Screening and clinical analysis of isovaleric acidemia newborn in Zhejiang province[J]. J Zhejiang Univ (Med Sci), 2020, 49(5): 556-564.

[2]	TONG Fan,YANG Rulai,LIU Chang,WU Dingwen,ZHANG Ting,HUANG Xinwen,HONG Fang,QIAN Guling,HUANG Xiaolei,ZHOU Xuelian,SHU Qiang,ZHAO Zhengyan. Screening for hereditary tyrosinemia and genotype analysis in newborns[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 459-464.

[3]	HUANG Xinwen, ZHANG Yu, HONG Fang, ZHENG Jing, YANG Jianbin, TONG Fan, MAO Huaqing, HUANG Xiaolei, ZHOU Xuelian, YANG Rulai, ZHAO Zhengyan. Screening for amino acid metabolic disorders of newborns in Zhejiang province:prevalence, outcome and follow-up[J]. J Zhejiang Univ (Med Sci), 2017, 46(3): 233-239.

[4]	HONG Fang, HUANG Xinwen, ZHANG Yu, YANG Jianbin, TONG Fan, MAO Huaqing, HUANG Xiaolei, ZHOU Xuelian, YANG Rulai, ZHAO Zhengyan. Screening for newborn organic aciduria in Zhejiang province:prevalence, outcome and follow-up[J]. J Zhejiang Univ (Med Sci), 2017, 46(3): 240-247.

[5]	SHEN Zhixin, GAO Enfang, WENG Wenqing, LUO Weiling. Hereditary vitreous degeneration muddy: report of ten cases[J]. J Zhejiang Univ (Med Sci), 2016, 45(6): 636-640.

[6]	Yin Jinfu, Yao Ke, Jiang Jiekai, et al. CLINICAL APPLICATION OF DYC-ⅠHYPOBARIC OPERATING TABLE[J]. J Zhejiang Univ (Med Sci), 1996, 25(6): 245-248.

Viewed

Full text

Abstract

Cited

Shared

Discussed